Part I Panel Questions
0:00 Introduction
1:22 How has the COVID-19 pandemic affected you?
4:09 What’s the most common question you’re getting and what is your response?
8:06 What adjustments have you made in your practice or how has your practice changed?
13:13 Things we are not doing anymore…
13:40 Questions amongst panelists
13:33 A Kavanaugh (to K Winthrop) What’s the evidence favoring the evidence hydroxychloroquine (French Study)
16:40 J Cush (to C Calabrese) Is azithromycin an effective COVID therapy?
17:45 C Calabrese (to K Winthrop) What about “Universal Masking”?
20:24 A Matsumoto (to ID docs CC, KW) When can patients (or healthcare workers) resume infliximab infusions after being symptomatic?
24:23 A Wells (to AK) what to do with trainees during this “shutdown”?
25:55 A Wells (to CC) What about the new 15 min test vs the ‘real time' (PCR) test?
26:22 J Cush on the Global Rheumatology Alliance - rheum-covid.org
27:25 Are Rheumatic patients “at-risk” for COVID-19 infection or worse outcomes?